Investing Center Preview – Manage your investments and watch your net worth grow.
APVO:NASDAQ – Small Cap Stock (Biotechnology)
Aptevo Therapeutics Inc – APVO Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
1.12 | 0.12 (+12.21%) | 0.94 - 180.19 | 73.3 thousand (Above Avg) |
Market data as of 11:06AM 04/02/25. Quotes are delayed by at least 15 min.
Overview - APVO
Open | 1.00 |
---|---|
Previous Close | 1.00 |
Day's Range | 1.00 - 1.15 |
Market Cap | 1.6M |
Avg Volume (10 Day) | 170.3K |
Price/Earnings (Trailing 12 Mo.) | -- |
Earnings Per Share (Trailing 12 Mo.) | -973.021 |
Dividend Yield | No Dividend |
One-Click Scorecard - APVO


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Neutral |
Increased shareholder value? | Neutral |
Consistently increased owner earnings? | Fail |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Neutral |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Pass |
Stock is undervalued? | Pass |
Have investors caught on? | Pass |
Has support of institutional investors? | Fail |
Has sufficient liquidity? | Pass |
Latest Headlines - APVO
No news headlines available for APVO
Industry Position - APVO
APVO | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 0.00% | |
Net Income Growth (1yr) | -- | |
Total Debt/Equity | 0.97 | |
LT Debt/Equity | 0.97 | |
Earnings Yield | -- | |
Price/Sales | -- |
Competitors - APVO
Company | Last | Change |
---|---|---|
Protagenic Therapeutics Inc | 0.24 | -3.96% |
Panbela Therapeutics Inc | 0.32 | 0.00% |
Helix BioMedix Inc | 7.18 | 0.00% |
Virpax Pharmaceuticals Inc | 1.35 | +5.08% |
Doseology Sciences Inc | 0.37 | 0.00% |
Data is delayed by at least 15 min.